UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pfizer strives to save blockbuster anti-smoking drug
by So Jae-hyeon
2018-05-28 11:57
Korean drugmakers raid ‘pharmerging’ markets
by So Jae-hyeon
2018-05-25 14:32
Local drugs to challenge Parkinson’s disease treatment Azilect
by So Jae-hyeon
2018-05-23 15:42
Dongwha, Hugel boost Q1 earnings under new CEO
by So Jae-hyeon
2018-05-17 11:45
Hanyang rheumatic disease hospital to focus on intractable diseases
by So Jae-hyeon
2018-05-16 15:21
라인
Warm inter-Korean relations may benefit GC Pharma, Dong-A ST
by So Jae-hyeon
2018-05-15 15:50
‘FDA is adapting to fast-changing digital healthcare’
by So Jae-hyeon
2018-05-11 16:22
‘Open innovation a must in new drug development'
by So Jae-hyeon
2018-05-10 16:05
How are Korean drugmakers faring in US?
by So Jae-hyeon
2018-05-09 15:55
Hanmi wins FDA nod for arthritis treatment Hyalrheuma
by So Jae-hyeon
2018-05-09 11:59
라인
Boryung’s antihypertensive drug Kanarb tops output among new drugs
by So Jae-hyeon
2018-05-08 16:05
Daewoong to seek US nod for liver drug Ursa this year
by So Jae-hyeon
2018-05-08 14:37
Korean pharma firms target rare diseases to enter US market
by So Jae-hyeon
2018-04-30 16:42
Why is Medipost enhancing cord blood biz?
by So Jae-hyeon
2018-04-26 16:44
Drugmakers compete to develop liver drugs
by So Jae-hyeon
2018-04-20 14:18
라인
Blockbuster Remicade losing out to Korean biosimilars in US
by So Jae-hyeon
2018-04-19 15:39
Pharma sector embraces work-life balance
by So Jae-hyeon
2018-04-19 14:25
How are Korean drugmakers performing in China?
by So Jae-hyeon
2018-04-17 15:12
Will anti-smoking drug Champix still be champion?
by So Jae-hyeon
2018-04-16 14:46
SillaJen reveals clinical results on Pexa-Vec in UK
by So Jae-hyeon
2018-04-13 16:38
-
1
2
3
4
5
6
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top